HOMCY CHARLES J
SEC insider (Form 3/4/5 filer). CIK 0001192591. Director at BridgeBio Pharma, Inc. (BBIO) and 1 other issuer. 24 reported Form 4/5 transactions since Sep 2024; latest on Jun 22, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies HOMCY CHARLES J has filed insider reports for
- BridgeBio Pharma, Inc. (BBIO): Director
- Maze Therapeutics, Inc. (MAZE): Director
HOMCY CHARLES J
CIK: 0001192591
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- Jun 22, 2026BBIO
BridgeBio Pharma, Inc.
AwardDirect4K shares- - Jun 20, 2026BBIO
BridgeBio Pharma, Inc.
Tax PaymentDirect788 shares at avg. $66.27$52K - Jun 8, 2026MAZE
Maze Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
18K shares- - May 4, 2026MAZE
Maze Therapeutics, Inc.
GiftDirect7.4K shares- - Nov 19, 2025MAZE
Maze Therapeutics, Inc.
OtherDirect1.5K shares- - Oct 23, 2025MAZE
Maze Therapeutics, Inc.
GiftDirect28.4K shares- - Sep 22, 2025MAZE
Maze Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
18K shares- - Aug 11, 2025BBIO
BridgeBio Pharma, Inc.
SaleDirect50K shares at avg. $48.00$2.4M - Aug 8, 2025BBIO
BridgeBio Pharma, Inc.
SaleDirect191.7K shares at avg. $45.87$8.8M - Aug 8, 2025BBIO
BridgeBio Pharma, Inc.
SaleDirect58.3K shares at avg. $46.64$2.7M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 22, 2026 |  BBIO BridgeBio Pharma, Inc. | Award | 3,990 | - | $0 | Direct |
| Jun 20, 2026 | BBIO BridgeBio Pharma, Inc. | Tax Payment | 788 | $66.27 | $52,221 | Direct |
| Jun 8, 2026 |  MAZE Maze Therapeutics, Inc. | Award Stock Option (Right to Buy) | 18,000 | - | - | Direct |
| May 4, 2026 | MAZE Maze Therapeutics, Inc. | Gift | 7,422 | - | $0 | Direct |
| Nov 19, 2025 | MAZE Maze Therapeutics, Inc. | Other | 1,489 | - | - | Direct |
| Oct 23, 2025 | MAZE Maze Therapeutics, Inc. | Gift | 28,423 | - | - | Direct |
| Sep 22, 2025 | MAZE Maze Therapeutics, Inc. | Award Stock Option (Right to Buy) | 18,000 | - | - | Direct |
| Aug 11, 2025 | BBIO BridgeBio Pharma, Inc. | Sale | 50,000 | $48.00 | $2,400,000 | Direct |
| Aug 8, 2025 | BBIO BridgeBio Pharma, Inc. | Sale | 191,662 | $45.87 | $8,791,593 | Direct |
| Aug 8, 2025 | BBIO BridgeBio Pharma, Inc. | Sale | 58,338 | $46.64 | $2,720,849 | Direct |
1-10 of 24 transactions